Literature DB >> 12060603

Upregulation of renal BSC1 and TSC in prenatally programmed hypertension.

Jennifer Manning1, Kathleen Beutler, Mark A Knepper, V Matti Vehaskari.   

Abstract

Prenatal factors, especially intrauterine growth retardation, have been shown to correlate with the risk of essential hypertension in adult life, but the mechanisms are unknown. An experimental model of prenatal programming of hypertension in the rat, induced by a maternal low-protein diet during pregnancy, was employed to study the role of renal Na reabsorption in the pathogenesis. The abundance of the apical Na transporter type III Na/H exchanger (NHE3), bumetanide-sensitive Na-K-2Cl cotransporter (BSC1), thiazide-sensitive Na-Cl cotransporter (TSC), and the amiloride-sensitive epithelial Na channel (ENaC) was determined by semiquantitative immunoblotting in kidneys from the offspring at 4 wk of age, before hypertension became manifest. There were no significant differences between the experimental and control rats in the abundance of NHE3 or any of the ENaC subunits. In contrast, the quantity of BSC1 in the experimental group was increased to 302% of control (P < 0.001) and that of TSC to 157% of control (P < 0.05). Determination of specific mRNA levels by ELISA-linked RT-PCR revealed a significantly increased BSC1 mRNA at 1 day (P < 0.01), 4 wk (P < 0.01), and 8 wk (P < 0.001) of age, and a significantly increased TSC mRNA at 4 wk of age (P < 0.05) in the experimental group. The results suggest that prenatal programming of hypertension involves transcriptional upregulation of Na transport in thick ascending limb and distal convoluted tubule.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12060603     DOI: 10.1152/ajprenal.00358.2001

Source DB:  PubMed          Journal:  Am J Physiol Renal Physiol        ISSN: 1522-1466


  50 in total

1.  Baa, Baa, black sheep, are your kidneys full?

Authors:  Friedrich C Luft
Journal:  J Physiol       Date:  2003-05-02       Impact factor: 5.182

Review 2.  Molecular physiology of cation-coupled Cl- cotransport: the SLC12 family.

Authors:  Steven C Hebert; David B Mount; Gerardo Gamba
Journal:  Pflugers Arch       Date:  2003-05-09       Impact factor: 3.657

3.  Evidence that prenatal programming of hypertension by dietary protein deprivation is mediated by fetal glucocorticoid exposure.

Authors:  Sabeen Habib; Jyothsna Gattineni; Katherine Twombley; Michel Baum
Journal:  Am J Hypertens       Date:  2010-08-19       Impact factor: 2.689

Review 4.  Developmental origins of adult hypertension: new insights into the role of the kidney.

Authors:  V Matti Vehaskari
Journal:  Pediatr Nephrol       Date:  2006-11-18       Impact factor: 3.714

Review 5.  Prenatal programming-effects on blood pressure and renal function.

Authors:  Eberhard Ritz; Kerstin Amann; Nadezda Koleganova; Kerstin Benz
Journal:  Nat Rev Nephrol       Date:  2011-02-01       Impact factor: 28.314

6.  Blood pressure follows the kidney: Perinatal influences on hereditary hypertension.

Authors:  Maarten P Koeners; Branko Braam; Jaap A Joles
Journal:  Organogenesis       Date:  2008-07       Impact factor: 2.500

Review 7.  How the kidney is impacted by the perinatal maternal environment to develop hypertension.

Authors:  Ana D Paixão; Barbara T Alexander
Journal:  Biol Reprod       Date:  2013-12-19       Impact factor: 4.285

Review 8.  Role of renal sympathetic nerve activity in prenatal programming of hypertension.

Authors:  Michel Baum
Journal:  Pediatr Nephrol       Date:  2016-03-21       Impact factor: 3.714

9.  Prenatal dexamethasone programs hypertension and renal injury in the rat.

Authors:  Luis A Ortiz; Albert Quan; Francisco Zarzar; Arthur Weinberg; Michel Baum
Journal:  Hypertension       Date:  2003-02       Impact factor: 10.190

10.  Prenatal programming of hypertension induces sympathetic overactivity in response to physical stress.

Authors:  Masaki Mizuno; Khurrum Siddique; Michel Baum; Scott A Smith
Journal:  Hypertension       Date:  2012-11-12       Impact factor: 10.190

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.